Pharma Globenewswire

Autism-Spectrum-Disorder-Pipeline-Insights

Autism Spectrum Disorder Pipeline Insight 2025: Emerging Therapies, Clinical Trial Updates, and Regulatory Progress

4 February 2026

The Autism Spectrum Disorder (ASD) Pipeline Insight 2025 highlights a rapidly evolving therapeutic landscape, driven by increasing disease prevalence, advances in neurodevelopmental research, and growing investment in precision medicine. According to DelveInsight, more than 18 biopharmaceutical companies are actively developing 20+ investigational

Clinical Trials

The FDA Grants Fast Track Designation to Novel GPRC5D/CD3 Bispecific Antibody LBL‑034 for Relapsed/Refractory Multiple Myeloma

4 February 2026

The Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to LBL‑034, an investigational GPRC5D/CD3 bispecific T‑cell engager, for the treatment of patients with relapsed or refractory multiple myeloma. The designation is based on encouraging safety, efficacy, and durability signals

Uncategorised

Global Colorectal Surgical Devices Market Expected to Grow at a Steady CAGR of ~8% Through 2032 | DelveInsight

3 February 2026

DelveInsight’s Colorectal Surgical Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Colorectal Surgical Devices Companies market shares, challenges, Colorectal Surgical Devices Market Drivers, barriers, trends, and key market Colorectal Surgical Devices companies in the market. To read more

Uncategorised

PDE4B Inhibitors Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

3 February 2026

DelveInsight’s “PDE4B Inhibitor Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the PDE4B inhibitor, historical and projected epidemiological data, competitive landscape as well as the PDE4B inhibitor therapeutics market trends in the United States, EU4

Uncategorised

Myelofibrosis Market Size is projected to grow at a CAGR of 9.00% by 2034, estimates DelveInsight

3 February 2026

DelveInsight’s “Myelofibrosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Discover

Uncategorised

Chronic Gout Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

3 February 2026

DelveInsight’s “Chronic Gout Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Chronic Gout, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and

Uncategorised

Bone Marrow Failure Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

3 February 2026

DelveInsight’s “Bone Marrow Failure Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Bone Marrow Failure, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United

Uncategorised

Hodgkin’s Lymphoma Market Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

3 February 2026

DelveInsight’s “Hodgkin’s Lymphoma Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Hodgkin’s Lymphoma, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and

Uncategorised

Pharmaceuticals Market Size is estimated to grow at a CAGR of 6.54%, estimates DelveInsight

3 February 2026

DelveInsight’s Pharmaceuticals Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceuticals Companies market shares, challenges, Pharmaceuticals Market Drivers, barriers, trends, and key market Pharmaceuticals companies in the market. To read more about the latest highlights related to

Latest

Autism Spectrum Disorder Pipeline Insight 2025: Emerging Therapies, Clinical Trial Updates, and Regulatory Progress

The FDA Grants Fast Track Designation to Novel GPRC5D/CD3 Bispecific Antibody LBL‑034 for Relapsed/Refractory Multiple Myeloma

Global Colorectal Surgical Devices Market Expected to Grow at a Steady CAGR of ~8% Through 2032 | DelveInsight

PDE4B Inhibitors Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

Myelofibrosis Market Size is projected to grow at a CAGR of 9.00% by 2034, estimates DelveInsight

Chronic Gout Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

Bone Marrow Failure Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

Hodgkin’s Lymphoma Market Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

Pharmaceuticals Market Size is estimated to grow at a CAGR of 6.54%, estimates DelveInsight

Recent Posts

Recent Comments

Hi There!

Banner

Latest Interviews

Newsletter

Authors